Cargando…
32414 Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: A multicentre retrospective cohort study
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465237/ http://dx.doi.org/10.1016/j.jaad.2022.06.042 |
_version_ | 1784787751499988992 |
---|---|
author | Rankin, Brian D. Georgakopoulos, Jorge-Ryan Sachdeva, Muskaan |
author_facet | Rankin, Brian D. Georgakopoulos, Jorge-Ryan Sachdeva, Muskaan |
author_sort | Rankin, Brian D. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9465237 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Published by Mosby, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94652372022-09-12 32414 Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: A multicentre retrospective cohort study Rankin, Brian D. Georgakopoulos, Jorge-Ryan Sachdeva, Muskaan J Am Acad Dermatol Honorable Mention Published by Mosby, Inc. 2022-09 2022-09-12 /pmc/articles/PMC9465237/ http://dx.doi.org/10.1016/j.jaad.2022.06.042 Text en Copyright © 2022 Published by Mosby, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Honorable Mention Rankin, Brian D. Georgakopoulos, Jorge-Ryan Sachdeva, Muskaan 32414 Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: A multicentre retrospective cohort study |
title | 32414 Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: A multicentre retrospective cohort study |
title_full | 32414 Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: A multicentre retrospective cohort study |
title_fullStr | 32414 Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: A multicentre retrospective cohort study |
title_full_unstemmed | 32414 Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: A multicentre retrospective cohort study |
title_short | 32414 Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: A multicentre retrospective cohort study |
title_sort | 32414 incidence and prognosis of covid-19 in patients with atopic diseases on dupilumab: a multicentre retrospective cohort study |
topic | Honorable Mention |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465237/ http://dx.doi.org/10.1016/j.jaad.2022.06.042 |
work_keys_str_mv | AT rankinbriand 32414incidenceandprognosisofcovid19inpatientswithatopicdiseasesondupilumabamulticentreretrospectivecohortstudy AT georgakopoulosjorgeryan 32414incidenceandprognosisofcovid19inpatientswithatopicdiseasesondupilumabamulticentreretrospectivecohortstudy AT sachdevamuskaan 32414incidenceandprognosisofcovid19inpatientswithatopicdiseasesondupilumabamulticentreretrospectivecohortstudy |